Stay updated with breaking news from Senza Omnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nevro (NYSE:NVRO – Free Report) had its price objective reduced by Royal Bank of Canada from $39.00 to $33.00 in a research report sent to investors on Wednesday morning, Marketbeat.com reports. They currently have an outperform rating on the medical equipment provider’s stock. Several other brokerages have also recently issued reports on NVRO. StockNews.com assumed […]
Nevro (NYSE:NVRO – Get Free Report) had its target price decreased by equities researchers at Royal Bank of Canada from $39.00 to $33.00 in a report issued on Wednesday, FlyOnTheWall reports. Royal Bank of Canada’s target price points to a potential upside of 67.60% from the stock’s current price. A number of other equities research […]
Nevro (NYSE:NVRO – Get Free Report) had its target price cut by stock analysts at Morgan Stanley from $29.00 to $23.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has an “equal weight” rating on the medical equipment provider’s stock. Morgan Stanley’s target price indicates a potential upside of 14.66% from […]
Nevro (NYSE:NVRO – Get Free Report) had its price target decreased by research analysts at Morgan Stanley from $29.00 to $23.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an “equal weight” rating on the medical equipment provider’s stock. Morgan Stanley’s target price suggests a potential upside of […]
Nevro (NYSE:NVRO – Get Free Report) had its price objective reduced by stock analysts at Wells Fargo & Company from $27.00 to $23.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has an “equal weight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s target price would indicate a […]